Crinetics Approach

News Releases

News Releases

September 3, 2020
Crinetics Pharmaceuticals to Participate in September Investor Conferences
SAN DIEGO , Sept. 03, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals (Nasdaq: CRNX), today announced that management will participate in the following conferences in the month of September and invites investors to participate by webcast. Please see additional details below:   Baird Global